Outcomes of Health Care–Associated Pneumonia Empirically Treated with Guideline-Concordant Regimens Versus Community-Acquired Pneumonia Guideline–Concordant Regimens for Patients Admitted to Acute Care Wards from Home

Author:

Chen Jenny I1,Slater Leonard N2,Kurdgelashvili George3,Husain Khawaja O4,Gentry Chris A5

Affiliation:

1. Jenny I Chen PharmD, at time of writing, Infectious Diseases Pharmacy Resident, Pharmacy Service, Oklahoma City Veterans Affairs Medical Center, Oklahoma City, OK; now, Infectious Diseases Pharmacy Specialist, Inpatient Pharmacy Department, Kaiser Permanente Downey Medical Center, Downey, CA

2. Leonard N Slater MD, Chief, Infectious Diseases Section, Medical Service, Oklahoma City Veterans Affairs Medical Center; Professor, Department of Medicine, College of Medicine, University of Oklahoma, Oklahoma City

3. George Kurdgelashvili MD, Assistant Chief, Medical Service, Oklahoma City Veterans Affairs Medical Center; Clinical Assistant Professor, Department of Medicine, College of Medicine, University of Oklahoma

4. Khawaja O Husain MD, at time of writing, Infectious Diseases Fellow, Medical Service, Oklahoma City Veterans Affairs Medical Center; Department of Medicine, College of Medicine, University of Oklahoma; now, Hospitalist, Sound Physicians, Platte Valley Medical Center, Brighton, CO

5. Chris A Gentry PharmD BCPS, Associate Chief, Clinical Pharmacy Services and Clinical Specialist, Infectious Diseases Pharmacy Service (119), Oklahoma City Veterans Affairs Medical Center

Abstract

BACKGROUND The introduction of the health care–associated pneumonia (HCAP) categorization expanded recommendations for broad-spectrum empiric antibiotics to pneumonia patients presenting from the community with recent health care–system exposure. However, the efficacy of such regimens in improving clinical outcomes in these patients has not been well established. OBJECTIVE To compare the clinical outcomes of HCAP patients treated initially with HCAP guideline–concordant antibiotic regimens to those treated initially with community-acquired pneumonia (CAP) guideline-concordant antibiotic regimens. METHODS This retrospective study included HCAP patients presenting from home and admitted to general medical wards. HCAP regimen patients were treated empirically with at least 1 antipseudomonal agent. All other patients were assigned to the CAP regimen group. The primary end point was clinical cure at 30 days postdischarge. Subgroup analysis was performed in patients hospitalized 1–30 days and 31–90 days before the HCAP admission. RESULTS Of 228 HCAP admissions, 122 patients received CAP regimens and 106 received HCAP regimens. The 2 groups were similar at baseline, including Pneumonia Severity Index scores. Attributable clinical cure occurred in 75.4% of CAP regimen patients and 69.8% of HCAP regimen patients (p = 0.34). Overall clinical cure occurred in 59.8% of CAP regimen patients and 54.7% of HCAP regimen patients (p = 0.44). The CAP regimen group used fewer days of intravenous antibiotics (4.39 vs 7.75, p < 0.0001) and had shorter lengths of stay (6.36 vs 8.58 days, p < 0.0001). For patients hospitalized 31–90 days earlier, clinical cure was higher in the CAP regimen group (attributable, 82.9% vs 60.0%, p = 0.0090; overall, 67.1% vs 47.5%, p = 0.044). CONCLUSIONS Compared to CAP guideline–concordant regimens, treatment of HCAP with HCAP guideline–concordant regimens did not increase clinical cure rates and was associated with lower clinical cure rates in patients hospitalized 31–90 days prior to the HCAP admission. This study suggests that broad-spectrum empiric antibiotics may not be necessary in all HCAP patient groups.

Publisher

SAGE Publications

Subject

Pharmacology (medical)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3